Dec 20th, 2017. Sensorion, Cochlear to evaluate drug-implant combo in hearing loss.
By Cormac Sheridan and Tamra Sami. Buy a reprint to read.
Boursier.com : Interview of Nawal Ouzren, CEO Sensorion, Video (In French)
La Lettre M - Cochlear will invest around €1.6 million and receive an equity stake in Sensorion. Read (in French)
Sensorion announces oral presentation at the European Histamine Research Society. Read
Sensorion announces the positive Data Safety Monitoring Board (DSMB) review and continuation of the phase 2 clinical trial for SENS-111 in acute unilateral vestibulopathy (AUV). 86 patients enrolled in SENS-111 clinical trial. Read